Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 8, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Medtech
athenahealth Becomes First Healthcare IT Company to Fully Implement TEFCA, Pioneering Nationwide Data Interoperability
Life Sciences Times
-
July 29, 2025
0
Biotech
SpyBiotech Appoints Biotech Veteran Stuart Chaffee to Board of Directors
Life Sciences Times
-
July 29, 2025
0
Pharma
ViroCell and AvenCell Partner to Advance Allogeneic CAR-T Therapies for Blood Cancers
Life Sciences Times
-
July 29, 2025
0
People on the Move
ReAlta Life Sciences Appoints Ellen Lubman as Chief Business Officer to Drive Strategic Growth
Life Sciences Times
-
July 28, 2025
0
People on the Move
GoodRx Names Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
Life Sciences Times
-
July 28, 2025
0
Pharma
AstraZeneca’s IMFINZI® Receives Priority Review and Breakthrough Designation from FDA for Early-Stage Gastric and GEJ Cancers
Life Sciences Times
-
July 28, 2025
0
Medtech
Cognito Therapeutics Unveils Promising Spectris™ Data for Alzheimer’s at AAIC 2025
Life Sciences Times
-
July 28, 2025
0
Pharma
Deciphera’s Vimseltinib Wins Positive CHMP Opinion for Rare Joint Tumor Treatment in EU
Life Sciences Times
-
July 28, 2025
0
Medtech
AngioDynamics Launches AMBITION BTK Trial with First Patient Enrolled to Explore Advanced Treatment for Critical Limb Ischemia
Life Sciences Times
-
July 28, 2025
0
People on the Move
Cristian Massacesi, M.D., Appointed Chief Medical Officer and Head of Development at Bristol Myers Squibb
Life Sciences Times
-
July 25, 2025
0
1
...
141
142
143
...
836
Page 142 of 836
Most Popular
WHOOP Expands Health Platform With Clinician Access and AI Features
May 8, 2026
Reprieve Cardiovascular Reports Published Pilot Trial Results for Heart Failure Therapy
May 8, 2026
Stoke Therapeutics Advances Dravet Syndrome Drug as Phase 3 Study Nears Enrollment Goal
May 8, 2026
Myomo Revenue Rises as Company Expands Recurring Patient Sources
May 8, 2026
Load more
Recent Comments
Recent Comments